1. Home
  2. ILMN vs SYF Comparison

ILMN vs SYF Comparison

Compare ILMN & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.74

Market Cap

19.4B

Sector

Health Care

ML Signal

HOLD

SYF

Synchrony Financial

HOLD

Current Price

$75.75

Market Cap

25.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ILMN
SYF
Founded
1998
1932
Country
United States
United States
Employees
N/A
20000
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
19.4B
25.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ILMN
SYF
Price
$134.74
$75.75
Analyst Decision
Hold
Buy
Analyst Count
17
19
Target Price
$124.24
$84.83
AVG Volume (30 Days)
1.3M
3.4M
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
1.60%
EPS Growth
170.87
N/A
EPS
5.45
N/A
Revenue
$4,343,000,000.00
N/A
Revenue This Year
$6.47
$84.92
Revenue Next Year
$5.58
$5.11
P/E Ratio
$23.49
$7.85
Revenue Growth
N/A
N/A
52 Week Low
$73.86
$52.99
52 Week High
$155.53
$88.77

Technical Indicators

Market Signals
Indicator
ILMN
SYF
Relative Strength Index (RSI) 58.53 57.30
Support Level $127.99 $74.95
Resistance Level $137.09 $77.41
Average True Range (ATR) 5.00 1.93
MACD -0.09 -0.24
Stochastic Oscillator 83.67 29.10

Price Performance

Historical Comparison
ILMN
SYF

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: